Molecular and functional characterization of CBAVD-causing mutations located in CFTR nucleotide-binding domains

Cellular Physiology and Biochemistry

Volumn 22, Issue 1-4, 2008, Pages 79-92

  Grangeia, Ana ^a   Barro Soria, René ^b   Carvalho, Filipa ^a   Damas, Ana M ^c,d   Maurício, Ana Colette ^d   Kunzelmann, Karl ^b   Barros, Alberto ^a,e   Sousa, Mário ^a,e  

^a University of Porto   (Portugal)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c UNIVERSITY OF PORTO   (Portugal)

^d Department of Veterinary Clinics ^*  (Portugal)

^e UNIVERSITY OF PORTO   (Portugal)

Author keywords

CFTR; CFTR gene mutation; Chloride channel; Cystic fibrosis; Male infertility; Vas deferens

Indexed keywords

CHLORIDE CHANNEL; NUCLEOTIDE BINDING PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADULT; ARTICLE; CASE REPORT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE MUTATION; GENETIC SCREENING; GENOTYPE; HETEROZYGOSITY; HUMAN; MALE; MALE INFERTILITY; PRIORITY JOURNAL; VAS DEFERENS;

EID: 51149085670     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000149785     Document Type: Article

References (49)

1. Welsh MJ, Ramsey BW, Accurso F and Cutting GR: Cystic fibrosis. In The Metabolic Basis of Inherited Disease. C.L. Scriver, A.L. Beaudet, W.S. Sly, and D. Valle, editors. McGraw-Hill, New York, USA, 2001;3799-3876.
2. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok S, Plavsic N, Chou JL, Drumm ML, Iannuzzi MC, Collins FS and Tsui LC: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989;245:1066-1073.
3. Rosenstein BJ and Cutting GR: The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998;132:589-595.
4. Higgins CF and Linton KJ: The ATP switch model for ABC transporters. Nat Struct Mol Biol 2004;11:918-926.
5. Hyde SC, Emsley P, Hartshorn MJ, Mimmack MM, Gileadi U, Pearce SR, Gallagher MP, Gill DR, Hubbard RE and Higgins CF: Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature 1990;346:362-365.
6. Dawson RJ and Locher KP: Structure of a bacterial multidrug ABC transporter. Nature 2006;443:180-185.
7. Locher KP, Lee AT and Rees DC: The E. coli BtuCD structure: a framework for ABC transporter architecture and mechanism. Science 2002;296:1091-1098.
8. Hopfner KP, Karcher A, Shin DS, Craig L, Arthur LM, Carney JP and Tainer JA: Structural biology of Rad50 ATPase: ATP-driven conformational control in DNA double-strand break repair and the ABC-ATPase superfamily. Cell 2000;101:789-800.
9. Hung LW, Wang IX, Nikaido K, Liu PQ, Ames GF and Kim SH: Crystal structure of the ATP-binding subunit of an ABC transporter. Nature 1998;396:703-707.
10. Zaitseva J, Jenewein S, Jumpertz T, Holland IB and Schmitt L: H662 is the linchpin of ATP hydrolysis in the nucleotide-binding domain of the ABC transporter HlyB. Embo J 2005:24;1901-1910.
11. Schneider E and Hunke S: ATP-binding-cassette (ABC) transport systems: functional and structural aspects of the ATP-hydrolyzing subunits/domains. FEMS Microbiol Rev 1998;22:1-20.
12. Carson MR, Travis SM and Welsh MJ: The two nucleotide-binding domains of cystic fibrosis transmembrane conductance regulator (CFTR) have distinct functions in controlling channel activity. J Biol Chem 1995;270:1711-1717.
13. Gadsby DC and Nairn AC: Control of CFTR channel gating by phosphorylation and nucleotide hydrolysis. Physiol Rev 1999;79:S77-107.
14. Gadsby DC, Vergani P and Csanady L: The ABC protein turned chloride channel whose failure causes cystic fibrosis. Nature 2006;440:477-483.
15. Sheppard DN and Welsh MJ: Structure and function of the CFTR chloride channel. Physiol Rev 1999;79:S23-45.
16. Welsh MJ and Smith AE: Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993;73:1251-1254.
17. Kaplan E, Shwachman H, Perlmutter AD, Rule A, Khaw KT and Holsclaw DS: Reproductive failure in males with cystic fibrosis. N Engl J Med 1968;279:65-69.
18. Landing BH, Wells TR and Wang CI: Abnormality of the epididymis and vas deferens in cystic fibrosis. Arch Pathol 1969;88:569-580.
19. Dumur V, Gervais R, Rigot JM, Lafitte JJ, Manouvrier S, Biserte J, Mazeman E and Roussel P: Abnormal distribution of CF delta F508 allele in azoospermic men with congenital aplasia of epididymis and vas deferens. Lancet 1990;336:512.
20. Anguiano A, Oates RD, Amos JA, Dean M, Gerrard B, Stewart C, Maher TA, White MB and Milunsky A: Congenital bilateral absence of the vas deferens. A primarily genital form of cystic fibrosis. Jama 1992;267:1794-1797.
21. Chillon M, Casals T, Mercier B, Bassas L, Lissens W, Silber S, Romey MC, Ruiz-Romero J, Verlingue C, Claustres M, Nunes V, Férec C, and Estivill X: Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 1995;332:1475-1480.
22. Lissens W, Mercier B, Tournaye H, Bonduelle M, Ferec C, Seneca S, Devroey P, Silber S, Van Steirteghem A and Liebaers I: Cystic fibrosis and infertility caused by congenital bilateral absence of the vas deferens and related clinical entities. Hum Reprod 1996;11:55-78.
23. Grangeia A, Niel F, Carvalho F, Fernandes S, Ardalan A, Girodon E, Silva J, Ferras L, Sousa M and Barros A: Characterization of cystic fibrosis conductance transmembrane regulator gene mutations and IVS8 poly(T) variants in Portuguese patients with congenital absence of the vas deferens. Hum Reprod 2004;19:2502-2508.
24. Grangeia A, Sá R, Carvalho F, Martin J, Girodon E, Silva J, Ferras L, Barros A and Sousa M: Molecular characterisation of the cystic fibrosis transmembrane conductance regulator gene in congenital absence of the vas deferens. Genet Med 2007;9:163-172.
25. Claustres M: Molecular pathology of the CFTR locus in male infertility. Reprod. Biomed. Online 2005;10:14-41.
26. Ratbi I, Legendre M, Niel F, Martin J, Soufir JC, Izard V, Costes B, Costa C, Goossens M, Girodon E: Detection of cystic fibrosis transmembrane conductance regulator (CFTR) gene rearrangements enriches the mutation spectrum in congenital bilateral absence of the vas deferens and impacts on genetic counselling. Hum Reprod 2007;22(5):1285-1291.
27. Claustres M, Guittard C, Bozon D, Chevalier F, Verlingue C, Ferec C, Girodon E, Cazeneuve C, Bienvenu T, Lalau G, Dumur V, Feldmann D, Bieth E, Blayau M, Clavel C, Creveaux I, Malinge MC, Monnier N, Malzac P, Mittre H, Chomel JC, Bonnefont JP, Iron A, Chery M and Des Georges M: Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum Mutat 2000;16:143-156.
28. Sousa M, Cremades N, Silva J, Oliveira C, Ferraz L, Teixeira da Silva J, Viana P and Barros A: Predictive value of testicular histology in secretory azoospermic subgroups and clinical outcome after microinjection of fresh and frozen-thawed sperm and spermatids. Hum Reprod 2002;17:1800-1810.
29. Costes B, Girodon E, Ghanem N, Flori E, Jardin A, Soufir JC and Goossens M: Frequent occurrence of the CFTR intron 8 (TG)n 5T allele in men with congenital bilateral absence of the vas deferens. Eur J Hum Genet 1995;3:285-293.
30. Fanen P, Ghanem N, Vidaud M, Besmond C, Martin J, Costes B, Plassa F and Goossens M: Molecular characterization of cystic fibrosis: 16 novel mutations identified by analysis of the whole cystic fibrosis conductance transmembrane regulator (CFTR) coding regions and splice site junctions. Genomics 1992;13:770-776.
31. Le Marechal C, Audrezet MP, Quere I, Raguenes O, Langonne S and Ferec C: Complete and rapid scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by denaturing high-performance liquid chromatography (D-HPLC): major implications for genetic counselling. Hum Genet 2001;108:290-298.
32. Lewis HA, Zhao X, Wang C, Sauder JM, Rooney I, Noland BW, Lorimer D, Kearins MC, Conners K, Condon B, Maloney PC, Guggino W, Hunt J and Emtage S: Impact of the deltaF508 mutation in first nucleotide-binding domain of human cystic fibrosis transmembrane conductance regulator on domain folding and structure. J Biol Chem 2005;280:1346-1353.
33. Smith PC, Karpowich N, Millen L, Moody JE, Rosen J, Thomas PJ and Hunt JF: ATP binding to the motor domain from an ABC transporter drives formation of a nucleotide sandwich dimer. Mol Cell 2002;10:139-149.
34. Chen J, Lu G, Lin J, Davidson AL and Quiocho FA: A tweezers-like motion of the ATP-binding cassette dimer in an ABC transport cycle. Mol Cell 2003;12:651-661.
35. Karpowich N, Martsinkevich O, Millen L, Yuan YR, Dai PL, MacVey K, Thomas PJ and Hunt JF: Crystal structures of the MJ1267 ATP binding cassette reveal an induced-fit effect at the ATPase active site of an ABC transporter. Structure 2001;9:571-586.
36. Lewis HA, Buchanan SG, Burley SK, Conners K, Dickey M, Dorwart M, Fowler R, Gao X, Guggino WB, Hendrickson WA, Hunt J, Kearins M, Lorimer D, Maloney PC, Post KW, Rajashankar KR, R ME, Sauder JM, Shriver S, Thibodeau PH, Thomas PJ, Zhang M, Zhao X and Emtage S: Structure of nucleotide-binding domain 1 of the cystic fibrosis transmembrane conductance regulator. Embo J 2004;23:282-293.
37. Galietta LJ, Haggie PM and Verkman AS: Green fluorescent protein-based halide indicators with improved chloride and iodide affinities. FEBS Lett 2001;499:220-224.
38. Spitzner M, Martins JR, Barro Soria R, Ousingsawat J, Scheidt K, Schreiber R, Kunzelmann K: Eag1 and Bestrophin 1 are upregulated in fast growing colonic cancer cells. J Biol Chem 2008;283:7421-7428.
39. Grangeia A, Carvalho F, Fernandes S, Silva J, Sousa M and Barros A: A novel missense mutation P1290S at exon-20 of the CFTR gene in a Portuguese patient with congenital bilateral absence of the vas deferens. Fertil Steril 2005;83:448-451.
40. Sheppard DN, Rich DP, Ostedgaard LS, Gregory RJ, Smith AE and Welsh MJ: Mutations in CFTR associated with mild-disease-form Cl- channels with altered pore properties. Nature 1993;362:160-164.
41. Beck S, Penque D, Garcia S, Gomes A, Farinha C, Mata L, Gulbenkian S, Gil-Ferreira K, Duarte A, Pacheco P, Barreto C, Lopes B, Cavaco J, Lavinha J and Amaral MD: Cystic fibrosis patients with the 3272-26A - >G mutation have mild disease, leaky alternative mRNA splicing, and CFTR protein at the cell membrane. Hum Mutat 1999;14:133-144.
42. Bienvenu T, Beldjord C, Kaplan JC, Hubert D and Dusser D: Severe cystic fibrosis phenotype in a delta F508/3272-26A - >G compound heterozygote. J Med Genet 1995;32:919.
43. Amaral MD., Pacheco P, Beck S, Farinha CM, Penque D, Nogueira P, Barreto C, Lopes B, Casals T, Dapena, Gartner S, Vásquez C, Pérez- Frías J, Olveira C, Cabanas R, Estivill X, Tzetis M, Kanavakis E, Doudounakis S, Dörk T, Tümmler B, Girodon-Boulandet E, Cazeneuve C, Goossens M, Blayau M, Verlingue C, Vieira I, Féréc C, Claustres M, des Georges M, Clavel C, Birembaut P, Hubert D, Bienvenu T, Adoun M, Chomel JC, De Boeck K, Cuppens H and Lavinha J: Cystic fibrosis patients with the 3272-26A>G splicing mutation have milder disease than F508del homozygotes: a large European study. J Med Genet 2001;38:777-783.
44. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW, White GA, O'Riordan CR and Smith AE: Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 1990;63:827-834.
45. Schrijver I, Ramalingam S, Sankaran R, Swanson S, Dunlop CL, Keiles S, Moss RB, Oehlert J, Gardner P, Wassman R and Kammesheidt: Diagnostic testing by CFTR gene mutation analysis in a large group of Hispanics: novel mutations and assessment of a population-specific mutation spectrum. J Mol Diagn 2005;7:289-299.
46. Lukacs GL, Mohamed A, Kartner N, Chang XB, Riordan JR and Grinstein S: Conformational maturation of CFTR but not its mutant counterpart (delta F508) occurs in the endoplasmic reticulum and requires ATP. Embo J 1994;13:6076-6086.
47. Gregory RJ, Rich DP, Cheng SH, Souza DW, Paul S, Manavalan P, Anderson MP, Welsh MJ and Smith AE: Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol 1991;11:3886-3893.
48. Yuan YR, Blecker S, Martsinkevich O, Millen L, Thomas PJ and Hunt JF: The crystal structure of the MJ0796 ATP-binding cassette. Implications for the structural consequences of ATP hydrolysis in the active site of an ABC transporter. J Biol Chem 2001;276:32313-32321.
49. Zielenski J: Genotype and phenotype in cystic fibrosis. Respiration 2000;67(2):117-133.